Hood River Capital Management LLC Moon Lake Immunotherapeutics Transaction History
Hood River Capital Management LLC
- $5.79 Billion
- Q4 2024
A detailed history of Hood River Capital Management LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Hood River Capital Management LLC holds 649,590 shares of MLTX stock, worth $27.2 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
649,590
Previous 646,662
0.45%
Holding current value
$27.2 Million
Previous $32.6 Million
5.87%
% of portfolio
0.6%
Previous 0.6%
Shares
2 transactions
Others Institutions Holding MLTX
# of Institutions
136Shares Held
58.1MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$828 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$356 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$140 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$116 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$91.6 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.55B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...